Treatments | Concentrations (ppm) | Larval mortality (%) | Regression equation | LC25 (LCL–UCL) (ppm) | LC75 (LCL–UCL) (ppm) | χ2 |
---|---|---|---|---|---|---|
Lufenuron | Control | 0.0 ± 0.0a | Y = 0.0883X + 10.333 | 166.114 (131.847–204.847) | 732.335 (645.223–815.608) | 9.338 n.s |
200 | 26.67 ± 2.27b | |||||
400 | 46.67 ± 1.77bc | |||||
600 | 66.33 ± 1.73 cd | |||||
800 | 76.67 ± 3.52de | |||||
1000 | 100.0 ± 0.0e | |||||
Flufenoxuron | Control | 0.0 ± 0.0a | Y = 0.2329X + 9.0854 | 68.332 (63.492–72.109) | 283.017 (238.019–326.082) | 5.319 n.s |
50 | 13.33 ± 0.78b | |||||
100 | 36.67 ± 1.54c | |||||
200 | 60.0 ± 2.0d | |||||
300 | 83.67 ± 1.37e | |||||
400 | 96.67 ± 3.12e | |||||
Hexaflumuron | Control | 0.0 ± 0.0a | Y = 0.2252X + 10.041 | 56.425 (50.545–63.379) | 248.450 (221.993–281.604) | 4.164 n.s |
50 | 20.0 ± 1.0b | |||||
100 | 33.633 ± 1.58b | |||||
200 | 56.67 ± 1.33c | |||||
300 | 76.67 ± 1.78d | |||||
400 | 100.0 ± 0.0e |